Suchergebnisse - "Fibrinolytic Agents"

PubPharm (34)

1

Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2) : a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial

enthalten in: Lancet (London, England) | 2023

von Wang, Y. | Li, S. | Pan, Y. | +70

CommentIn: Lancet. 2023 Feb 25;401(10377):618-619. - PMID 36774934

2

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT) : a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

enthalten in: Lancet (London, England) | 2022

von Menon, B. | Buck, B. | Singh, N. | +152

CommentIn: Lancet. 2022 Jul 16;400(10347):138-139. - PMID 35779556

3

Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke : an open-label, blinded-outcome, randomised non-inferiority trial

enthalten in: Lancet (London, England) | 2022

von Fischer, U. | Kaesmacher, J. | Strbian, D. | +155

CommentIn: Lancet. 2022 Jul 9;400(10346):76-78. - PMID 35810759

4

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED) : an international, randomised, open-label, blinded-endpoint, phase 3 trial

enthalten in: Lancet (London, England) | 2019

von Anderson, C. | Huang, Y. | Lindley, R. | +132

CommentIn: Lancet. 2019 Mar 2;393(10174):849-850. - PMID 30739748

5

Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke : results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial

enthalten in: Lancet (London, England) | 2017

von Hanley, D. | Lane, K. | McBee, N. | +39

CommentIn: Lancet. 2017 Feb 11;389(10069):575-576. - PMID 28081951

6

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI) : an open-label, randomised controlled trial

enthalten in: Lancet (London, England) | 2015

von Engstrøm, T. | Kelbæk, H. | Helqvist, S. | +46

CommentIn: Nat Rev Cardiol. 2015 Oct;12(10):560. - PMID 26303355

7

Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS) : a multinational open-label randomised trial

enthalten in: Lancet (London, England) | 2014

von Rodger, M. | Hague, W. | Kingdom, J. | +80

CommentIn: Lancet. 2014 Nov 8;384(9955):1648-9. - PMID 25066247

8

Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke : a randomised controlled trial

enthalten in: Lancet (London, England) | 2012

von Zinkstok, S. | Roos, Y. | ARTIS investigators | +74

CommentIn: Lancet. 2012 Aug 25;380(9843):706-8. - PMID 22748819

9

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]) : a randomised controlled trial

enthalten in: Lancet (London, England) | 2012

von IST-3 collaborative group | Sandercock, P. | Wardlaw, J. | +120

ErratumIn: Lancet. 2012 Aug 25;380(9843):730

10

Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation : an open-label, phase 3, randomised controlled trial

enthalten in: Lancet (London, England) | 2012

von Corbacioglu, S. | Cesaro, S. | Faraci, M. | +33

CommentIn: Lancet. 2012 Apr 7;379(9823):1277-8. - PMID 22364686